Association Between Left Ventricle Diastolic Dysfunction and Unfavorable Prognostic Markers in Patients with Aortic Insufficiency
- PMID: 28764216
- PMCID: PMC5535408
- DOI: 10.7860/JCDR/2017/23463.9974
Association Between Left Ventricle Diastolic Dysfunction and Unfavorable Prognostic Markers in Patients with Aortic Insufficiency
Abstract
Introduction: The presence of symptoms, systolic dysfunction and Left Ventricle (LV) dilation are considered unfavourable prognostic markers in Aortic Valve Insufficiency (AVI). The role of diastolic dysfunction, which is considered unfavourable outcome marker in cardiac pathologies, is not well established in AVI.
Aim: To evaluate if the presence of diastolic dysfunction may be associated with unfavourable prognostic markers in AVI patients.
Materials and methods: A cross-sectional prospective study was performed on 22 patients with moderate or severe AVI. They underwent clinical evaluation and transthoracic echocardiography. Associations between clinical, epidemiological and echocardiographic were evaluated by Student t-test for normally distributed variables or Mann-Whitney test for non-normal distribution. Comparison between proportions was performed by Chi-square test.
Results: There was an association between increased LV filling pressure, assessed by E' and E/E' of Mitral Tissue Doppler, and impaired LV systolic function, respectively: R = 0.563, R2 = 0.281; p = 0.008 and R = 0.639, R2 = 0.378; p = 0.002. The LV indexed mass also was inversely associated with the LV ejection fraction (R = 0.62, R2 = 0.35 and p = 0.003).
Conclusion: There was an association of LV diastolic dysfunction and ventricular hypertrophy with impaired left ventricle systolic function. Increased LV filling pressure and LV indexed mass should be considered in the management of AVI patients.
Keywords: Echocardiogram; Left ventricle filling pressure; Myocardial eccentric hypertrophy; Volume overload.
Figures
![[Table/Fig-2]:](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7335/5535408/eb6b15e3dee0/jcdr-11-OC09-g001.gif)
![[Table/Fig-3]:](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7335/5535408/8cd205be2f01/jcdr-11-OC09-g002.gif)
![[Table/Fig-4]:](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7335/5535408/f5afde7fbac6/jcdr-11-OC09-g003.gif)
References
-
- Tornos P, Sambola A, Permanyer-Miralda G, Evangelista A, Gomez Z, Soler-Soler J. Long-term outcome of surgically treated aortic regurgitation:influence of guideline adherence toward early surgery. J Am Coll Cardiol. 2006;47:1012–17. - PubMed
-
- Nishimura RA, Otto CA, Bonow RA, Carabello BA, Erwin JP, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease:a report of the American college of cardiology/American heart association task force on practice guidelines. Am Coll Cardiol. 2014;63(22):e57–e185. - PubMed
-
- Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two dimensional and Doppler echocardiography. J Am Soc Ecocardiogr. 2003;16:777–802. - PubMed
-
- Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure. Circulation. 2013;128:e240–e327. - PubMed
-
- Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA, et al. 2014/AHA/ACC guideline for the management of patients with valvular heart disease. JACC. 2014;63(22):57–185. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources